Medicare lowers rates for drugs; DEA amends multiple Rx regulations

Article Overview

This article covers a Medicare payment update for drugs furnished in hospital outpatient departments versus physician offices, and a separate DEA regulatory change involving multiple sequential prescriptions for controlled substances. It is relevant to billing professionals, coders, compliance staff, and clinicians who track federal reimbursement and prescribing policy changes. The piece provides a high-level summary of the policy updates, their effective timing, and the organizations involved.